Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Dextrans

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of February 14, 2024
    Enforcement Report - Week of February 14, 2024

    14 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-14-2024-75684.pdf

    FDA
    14 Feb 2024
    Share Share
    Enforcement Report - Week of November 29, 2023
    Enforcement Report - Week of November 29, 2023

    29 Nov 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-29-2023-18805.pdf

    FDA
    29 Nov 2023
    Share Share
    Novartis's $90 million Swiss factory to help solve cell therapy bottleneck
    Novartis's $90 million Swiss factory to help solve cell therapy bottleneck

    01 Dec 2019

    // John Miller REUTERS

    https://www.reuters.com/article/us-novartis-swiss-factory/novartiss-90-million-swiss-factory-to-help-solve-cell-therapy-bottleneck-idUSKBN1Y214Y

    John Miller REUTERS
    01 Dec 2019
    Share Share
    Health Canada Issues Recall of Pfizer Canada ULC LMD 10% IN DEXTROSE 5%
    Health Canada Issues Recall of Pfizer Canada ULC LMD 10% IN DEXTROSE 5%

    26 Sep 2019

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-pfizer-canada-ulc-lmd-10-in-dextrose-5-1569469093.pdf

    HEALTH CANADA
    26 Sep 2019
    Share Share
    Avedro Inc's Photrexa Viscous (Riboflavin 5 - Phosphate; Dextran) approved in US for treatment of Keratoconus
    Avedro Inc's Photrexa Viscous (Riboflavin 5 - Phosphate; Dextran) approved in US for treatment of Keratoconus

    15 Apr 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/avedro-incs-photrexa-viscous-riboflavin-5-phosphate-dextran-approved-in-us-treatment-of-keratoconus-1461067032.pdf

    FDA
    15 Apr 2016
    Share Share
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    02 May 2015

    // Eric Palmer FIERCE PHARMA MFG

    http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

    Eric Palmer FIERCE PHARMA MFG
    02 May 2015
    Share Share